|
⚲
|
| NAPO Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001188290 |
| Sale | 2009-05-12 ($0.5 M Offered, $0.5 M Sold) |
| Fund | |
| Phone | 6506161900 |
| Address | 250 E Grand Avenue South San Francisco, 94080 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Steven King | |
| Charles Thompson | |
| Lisa Conte | |
| Sir William Young | |
| Jack van Hulst | |
| Pravin Chaturvedi | |
| Thomas van Dyck | |
| Gregory Stock |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Logos Byonyks 1 Mar 2025 a Series of CGF2021 LLC
✚
|
0.0 | |
|
LogRock Inc.
✚
|
0.0 | |
|
Loh Gabriel
✚
|
0.0 | |
|
Lohmeier Michelle
✚
|
0.0 | |
|
LOKA Labs Inc.
✚
|
0.0 | |
|
Lokey James W
✚
|
0.0 | |
|
LoLa Capital Partners Growth I, LP
✚
|
0.0 | |
|
Lola Holdings LLC
✚
|
0.0 | |
|
Loma Negra Holding GmbH
✚
|
0.0 | |
|
Logan Ron M Jr
✚
|
0.0 |